866-997-4948(US-Canada Toll Free)

United States Psoriasis Drug Market Report 2018

Published By :

QYResearch

Published Date : Jul 2018

Category :

Pharmaceutical

No. of Pages : 112 Pages

In this report, the United States Psoriasis Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Psoriasis Drug in these regions, from 2013 to 2025 (forecast).

United States Psoriasis Drug market competition by top manufacturers/players, with Psoriasis Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
AbbVie
Johnson & Johnson
Bayer
Galderma
Bristol-Myers Squibb
Novartis
Pfizer
Merz Pharma
Valeant
LEO Pharma
GlaxoSmithKline

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
External Use
Oral
Injection
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Drugs Store

Table of Contents

United States Psoriasis Drug Market Report 2018
1 Psoriasis Drug Overview
1.1 Product Overview and Scope of Psoriasis Drug
1.2 Classification of Psoriasis Drug by Product Category
1.2.1 United States Psoriasis Drug Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Psoriasis Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 External Use
1.2.4 Oral
1.2.5 Injection
1.3 United States Psoriasis Drug Market by Application/End Users
1.3.1 United States Psoriasis Drug Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospital
1.3.3 Drugs Store
1.4 United States Psoriasis Drug Market by Region
1.4.1 United States Psoriasis Drug Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Psoriasis Drug Status and Prospect (2013-2025)
1.4.3 Southwest Psoriasis Drug Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Psoriasis Drug Status and Prospect (2013-2025)
1.4.5 New England Psoriasis Drug Status and Prospect (2013-2025)
1.4.6 The South Psoriasis Drug Status and Prospect (2013-2025)
1.4.7 The Midwest Psoriasis Drug Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Psoriasis Drug (2013-2025)
1.5.1 United States Psoriasis Drug Sales and Growth Rate (2013-2025)
1.5.2 United States Psoriasis Drug Revenue and Growth Rate (2013-2025)

2 United States Psoriasis Drug Market Competition by Players/Suppliers
2.1 United States Psoriasis Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Psoriasis Drug Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Psoriasis Drug Average Price by Players/Suppliers (2013-2018)
2.4 United States Psoriasis Drug Market Competitive Situation and Trends
2.4.1 United States Psoriasis Drug Market Concentration Rate
2.4.2 United States Psoriasis Drug Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Psoriasis Drug Manufacturing Base Distribution, Sales Area, Product Type

3 United States Psoriasis Drug Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Psoriasis Drug Sales and Market Share by Region (2013-2018)
3.2 United States Psoriasis Drug Revenue and Market Share by Region (2013-2018)
3.3 United States Psoriasis Drug Price by Region (2013-2018)

4 United States Psoriasis Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Psoriasis Drug Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Psoriasis Drug Revenue and Market Share by Type (2013-2018)
4.3 United States Psoriasis Drug Price by Type (2013-2018)
4.4 United States Psoriasis Drug Sales Growth Rate by Type (2013-2018)

5 United States Psoriasis Drug Sales (Volume) by Application (2013-2018)
5.1 United States Psoriasis Drug Sales and Market Share by Application (2013-2018)
5.2 United States Psoriasis Drug Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 United States Psoriasis Drug Players/Suppliers Profiles and Sales Data
6.1 AbbVie
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Psoriasis Drug Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 AbbVie Psoriasis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Johnson & Johnson
6.2.2 Psoriasis Drug Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Johnson & Johnson Psoriasis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Bayer
6.3.2 Psoriasis Drug Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Bayer Psoriasis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Galderma
6.4.2 Psoriasis Drug Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Galderma Psoriasis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Bristol-Myers Squibb
6.5.2 Psoriasis Drug Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Bristol-Myers Squibb Psoriasis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Novartis
6.6.2 Psoriasis Drug Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Novartis Psoriasis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Pfizer
6.7.2 Psoriasis Drug Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Pfizer Psoriasis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Merz Pharma
6.8.2 Psoriasis Drug Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Merz Pharma Psoriasis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Valeant
6.9.2 Psoriasis Drug Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Valeant Psoriasis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 LEO Pharma
6.10.2 Psoriasis Drug Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 LEO Pharma Psoriasis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
6.11 GlaxoSmithKline

7 Psoriasis Drug Manufacturing Cost Analysis
7.1 Psoriasis Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Psoriasis Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Psoriasis Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Psoriasis Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Psoriasis Drug Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Psoriasis Drug Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Psoriasis Drug Sales Volume Forecast by Type (2018-2025)
11.3 United States Psoriasis Drug Sales Volume Forecast by Application (2018-2025)
11.4 United States Psoriasis Drug Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Psoriasis Drug
Figure United States Psoriasis Drug Market Size (K Units) by Type (2013-2025)
Figure United States Psoriasis Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure External Use Product Picture
Figure Oral Product Picture
Figure Injection Product Picture
Figure United States Psoriasis Drug Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Psoriasis Drug by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Drugs Store Examples
Table Key Downstream Customer in Drugs Store
Figure United States Psoriasis Drug Market Size (Million USD) by Region (2013-2025)
Figure The West Psoriasis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Psoriasis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Psoriasis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Psoriasis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Psoriasis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Psoriasis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Psoriasis Drug Sales (K Units) and Growth Rate (2013-2025)
Figure United States Psoriasis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Psoriasis Drug Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Psoriasis Drug Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Psoriasis Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Psoriasis Drug Sales Share by Players/Suppliers
Figure 2017 United States Psoriasis Drug Sales Share by Players/Suppliers
Figure United States Psoriasis Drug Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Psoriasis Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Psoriasis Drug Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Psoriasis Drug Revenue Share by Players/Suppliers
Figure 2017 United States Psoriasis Drug Revenue Share by Players/Suppliers
Table United States Market Psoriasis Drug Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Psoriasis Drug Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Psoriasis Drug Market Share of Top 3 Players/Suppliers
Figure United States Psoriasis Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Psoriasis Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Psoriasis Drug Product Category
Table United States Psoriasis Drug Sales (K Units) by Region (2013-2018)
Table United States Psoriasis Drug Sales Share by Region (2013-2018)
Figure United States Psoriasis Drug Sales Share by Region (2013-2018)
Figure United States Psoriasis Drug Sales Market Share by Region in 2017
Table United States Psoriasis Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Psoriasis Drug Revenue Share by Region (2013-2018)
Figure United States Psoriasis Drug Revenue Market Share by Region (2013-2018)
Figure United States Psoriasis Drug Revenue Market Share by Region in 2017
Table United States Psoriasis Drug Price (USD/Unit) by Region (2013-2018)
Table United States Psoriasis Drug Sales (K Units) by Type (2013-2018)
Table United States Psoriasis Drug Sales Share by Type (2013-2018)
Figure United States Psoriasis Drug Sales Share by Type (2013-2018)
Figure United States Psoriasis Drug Sales Market Share by Type in 2017
Table United States Psoriasis Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Psoriasis Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Psoriasis Drug by Type (2013-2018)
Figure Revenue Market Share of Psoriasis Drug by Type in 2017
Table United States Psoriasis Drug Price (USD/Unit) by Types (2013-2018)
Figure United States Psoriasis Drug Sales Growth Rate by Type (2013-2018)
Table United States Psoriasis Drug Sales (K Units) by Application (2013-2018)
Table United States Psoriasis Drug Sales Market Share by Application (2013-2018)
Figure United States Psoriasis Drug Sales Market Share by Application (2013-2018)
Figure United States Psoriasis Drug Sales Market Share by Application in 2017
Table United States Psoriasis Drug Sales Growth Rate by Application (2013-2018)
Figure United States Psoriasis Drug Sales Growth Rate by Application (2013-2018)
Table AbbVie Basic Information List
Table AbbVie Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AbbVie Psoriasis Drug Sales Growth Rate (2013-2018)
Figure AbbVie Psoriasis Drug Sales Market Share in United States (2013-2018)
Figure AbbVie Psoriasis Drug Revenue Market Share in United States (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson Psoriasis Drug Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Psoriasis Drug Sales Market Share in United States (2013-2018)
Figure Johnson & Johnson Psoriasis Drug Revenue Market Share in United States (2013-2018)
Table Bayer Basic Information List
Table Bayer Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer Psoriasis Drug Sales Growth Rate (2013-2018)
Figure Bayer Psoriasis Drug Sales Market Share in United States (2013-2018)
Figure Bayer Psoriasis Drug Revenue Market Share in United States (2013-2018)
Table Galderma Basic Information List
Table Galderma Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Galderma Psoriasis Drug Sales Growth Rate (2013-2018)
Figure Galderma Psoriasis Drug Sales Market Share in United States (2013-2018)
Figure Galderma Psoriasis Drug Revenue Market Share in United States (2013-2018)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Psoriasis Drug Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Psoriasis Drug Sales Market Share in United States (2013-2018)
Figure Bristol-Myers Squibb Psoriasis Drug Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Psoriasis Drug Sales Growth Rate (2013-2018)
Figure Novartis Psoriasis Drug Sales Market Share in United States (2013-2018)
Figure Novartis Psoriasis Drug Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Psoriasis Drug Sales Growth Rate (2013-2018)
Figure Pfizer Psoriasis Drug Sales Market Share in United States (2013-2018)
Figure Pfizer Psoriasis Drug Revenue Market Share in United States (2013-2018)
Table Merz Pharma Basic Information List
Table Merz Pharma Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merz Pharma Psoriasis Drug Sales Growth Rate (2013-2018)
Figure Merz Pharma Psoriasis Drug Sales Market Share in United States (2013-2018)
Figure Merz Pharma Psoriasis Drug Revenue Market Share in United States (2013-2018)
Table Valeant Basic Information List
Table Valeant Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Valeant Psoriasis Drug Sales Growth Rate (2013-2018)
Figure Valeant Psoriasis Drug Sales Market Share in United States (2013-2018)
Figure Valeant Psoriasis Drug Revenue Market Share in United States (2013-2018)
Table LEO Pharma Basic Information List
Table LEO Pharma Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure LEO Pharma Psoriasis Drug Sales Growth Rate (2013-2018)
Figure LEO Pharma Psoriasis Drug Sales Market Share in United States (2013-2018)
Figure LEO Pharma Psoriasis Drug Revenue Market Share in United States (2013-2018)
Table GlaxoSmithKline Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Psoriasis Drug
Figure Manufacturing Process Analysis of Psoriasis Drug
Figure Psoriasis Drug Industrial Chain Analysis
Table Raw Materials Sources of Psoriasis Drug Major Players/Suppliers in 2017
Table Major Buyers of Psoriasis Drug
Table Distributors/Traders List
Figure United States Psoriasis Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Psoriasis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Psoriasis Drug Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Psoriasis Drug Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Psoriasis Drug Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Psoriasis Drug Sales Volume (K Units) Forecast by Type in 2025
Table United States Psoriasis Drug Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Psoriasis Drug Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Psoriasis Drug Sales Volume (K Units) Forecast by Application in 2025
Table United States Psoriasis Drug Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Psoriasis Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Psoriasis Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Psoriasis Drug Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *